Literature DB >> 9700832

Liverpool Seizure Severity Scale revisited.

G A Baker1, D F Smith, A Jacoby, J A Hayes, D W Chadwick.   

Abstract

The purpose of the study was to examine the psychometric properties of the revised Liverpool Seizure Severity Scale. The scale has been adapted to increase its content validity and its potential for detecting change attributable to antiepileptic drug treatment. Ninety-seven patients completed the revised scale of which 32 completed it for both major and minor seizures. Reliability of the revised scale was conducted using assessment of internal consistency and test-retest. T-tests were conducted to assess the ability of patients to differentiate between major and minor seizures on scores of the seizure-severity scale. The psychometric properties of the scale were not adversely affected by either the increase in the number of items or the additional response scores. Patients completing the two scales of major and minor seizures were able to reliably differentiate between the two. We have attempted to improve the Liverpool Seizure Severity Scale in order to enhance its reliability, validity and sensitivity to change. The amendments we have made have not adversely affected its psychometric properties and we hope that it will make it more acceptable for use in clinical trials of new antiepileptic drug treatment. The revised scale is currently being applied to a number of clinical trials.

Entities:  

Mesh:

Year:  1998        PMID: 9700832     DOI: 10.1016/s1059-1311(98)80036-8

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  17 in total

1.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

2.  A 6-month prospective randomized controlled trial of remotely delivered group format epilepsy self-management versus waitlist control for high-risk people with epilepsy.

Authors:  Martha Sajatovic; Kari Colon-Zimmermann; Mustafa Kahriman; Edna Fuentes-Casiano; Hongyan Liu; Curtis Tatsuoka; Kristin A Cassidy; Samden Lhatoo; Douglas Einstadter; Peijun Chen
Journal:  Epilepsia       Date:  2018-08-10       Impact factor: 5.864

3.  One-year follow-up of a remotely delivered epilepsy self-management program in high-risk people with epilepsy.

Authors:  Martha Sajatovic; Kari Colon-Zimmermann; Mustafa Kahriman; Edna Fuentes-Casiano; Christopher Burant; Michelle E Aebi; Kristin A Cassidy; Samden Lhatoo; Douglas Einstadter; Peijun Chen
Journal:  Epilepsy Behav       Date:  2019-05-21       Impact factor: 2.937

4.  Neurofeedback impacts cognition and quality of life in pediatric focal epilepsy: An exploratory randomized double-blinded sham-controlled trial.

Authors:  Leon Morales-Quezada; Diana Martinez; Mirret M El-Hagrassy; Ted J Kaptchuk; M Barry Sterman; Gloria Y Yeh
Journal:  Epilepsy Behav       Date:  2019-11-08       Impact factor: 2.937

5.  Relationship and sexual satisfaction are associated with better disease self-management in persons with epilepsy.

Authors:  Amanda N Gesselman; Rachel K Wion; Justin R Garcia; Wendy R Miller
Journal:  Epilepsy Behav       Date:  2021-04-21       Impact factor: 3.337

6.  Clinical- and cost-effectiveness of a nurse led self-management intervention to reduce emergency visits by people with epilepsy.

Authors:  Adam J Noble; Paul McCrone; Paul T Seed; Laura H Goldstein; Leone Ridsdale
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

7.  Protocol for the ENCODE trial: evaluating a novel online depression intervention for persons with epilepsy.

Authors:  Björn Meyer; Mario Weiss; Martin Holtkamp; Stephan Arnold; Katja Brückner; Johanna Schröder; Franziska Scheibe; Yvonne Nestoriuc
Journal:  BMC Psychiatry       Date:  2017-02-07       Impact factor: 3.630

Review 8.  Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements.

Authors:  Annabel Nixon; Cicely Kerr; Katie Breheny; Diane Wild
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

9.  The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial.

Authors:  Elizabeth Randell; Rachel McNamara; D Mark Davies; Eleri Owen-Jones; Nigel Kirby; Lianna Angel; Cheney Drew; Rebecca Cannings-John; Michelle Smalley; Anurag Saxena; Emer McDermott; Laura Stockwell; Petrus J de Vries; Kerry Hood; Julian R Sampson
Journal:  Trials       Date:  2016-08-11       Impact factor: 2.279

10.  Patients' Measurement Priorities for Remote Measurement Technologies to Aid Chronic Health Conditions: Qualitative Analysis.

Authors:  Sara Simblett; Faith Matcham; Hannah Curtis; Ben Greer; Ashley Polhemus; Jan Novák; Jose Ferrao; Peter Gamble; Matthew Hotopf; Vaibhav Narayan; Til Wykes
Journal:  JMIR Mhealth Uhealth       Date:  2020-06-10       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.